Delisting riskEarnings in 4d
BNR · NASDAQ · Medical - Diagnostics & Research

Burning Rock Biotech (ADR)

NGS oncology testing, hospital workflows, and biopharma development services.

$10.08
After-hours close0.00 (0.00%)
At close$10.08(+0.80%)
DateEstimateReportedSurprise
Sep 2026−$2.29
Jun 2026−$2.29−$0.20+91.3%
Jun 2026−$2.29
Mar 2026−$1.40−$0.21+85.0%
Nov 2025−$0.26
Sep 2025−$0.15

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Jun 2025
Mar 2025
Dec 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
Jun 2020
Mar 2020
Sep 2019
Jun 2019
Mar 2019
Dec 2018
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Sep 2, 2026−$2.29$19.2M
Jun 9, 2026−$2.29−$0.20+91.3%$19.2M$15.7M−18.3%
Jun 2, 2026−$2.29$19.2M
Mar 12, 2026−$1.40−$0.21+85.0%$18.1M
Nov 20, 2025−$0.26$18.5M
Sep 8, 2025−$0.15$20.7M

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Jun 6, 2025
Mar 25, 2025
Dec 3, 2024
Aug 22, 2024
May 29, 2024
Mar 28, 2024
Nov 30, 2023
Aug 31, 2023
May 30, 2023
Mar 28, 2023
Nov 15, 2022
Aug 31, 2022
May 31, 2022
Mar 21, 2022
Nov 15, 2021
Aug 31, 2021
May 25, 2021
Mar 10, 2021
Nov 20, 2020
Aug 11, 2020
Jun 12, 2020
Mar 31, 2020
Sep 30, 2019
Jun 30, 2019
Mar 31, 2019
Dec 31, 2018